APH vs EBS
Amphenol Corporation (APH) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the APH and EBS stock pages for the full models.
Not investment advice.